Regarding all the difficulties mentioned above, the main aim of this study was to design liposomes with simvastatin incorporated into the liposome bilayer, selectively targeted towards breast cancer cells overexpressing HER2. This evidence concerns the gene ERBB2 and breast carcinoma.